EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Trajan Group Holdings's enterprise value is A$211.2 Mil.
Trajan Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$8.6 Mil. Therefore, Trajan Group Holdings's EV-to-EBITDA for today is 24.45.
The historical rank and industry rank for Trajan Group Holdings's EV-to-EBITDA or its related term are showing as below:
ASX:TRJ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 14.43 Med: 30.83 Max: 81.89
Current: 24.44
During the past 3 years, the highest EV-to-EBITDA of Trajan Group Holdings was 81.89. The lowest was 14.43. And the median was 30.83.
ASX:TRJ's EV-to-EBITDA is ranked worse than 72.43% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 15.12
vs ASX:TRJ: 24.44
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Trajan Group Holdings EV-to-EBITDA Historical Data
The historical data trend for Trajan Group Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Trajan Group Holdings's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's EV-to-EBITDA falls into.
Trajan Group Holdings's current Enterprise Value is A$211.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$8.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (ASX:TRJ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Trajan Group Holdings's PE Ratio for today is calculated as:
Trajan Group Holdings's share price for today is A$1.07.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Trajan Group Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Trajan Group Holdings (ASX:TRJ) Business Description
Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:TRJ has been successfully added to your